MECOM or PRDM16 rearrangements in AML share mutual biological features, such as the presence of micromegakaryocytes, low myeloperoxidase-expressing blasts, multilineage dysplasia, and poor prognosis [46]. Here, PRDM16 is linked to acute myeloid leukemia.